Combiwave SF250 (Salmeterol 25mcg/actuation and Fluticasone Propionate 250mcg/actuation Pressurised Inhalation)
Category: Drug Info
Specifications
Details
Manufacturer
GLENMARK PHARMACEUTICALS LTD(INDIA)
Registraction Number
MAL14125084AZ
Here’s a summary of the requested details for Combiwave SF250:
Contents
Active Ingredients:Salmeterol Xinafoate (equivalent to Salmeterol 25 mcg/actuation): A long-acting beta2-adrenergic agonist.
Fluticasone Propionate (250 mcg/actuation): A corticosteroid with potent anti-inflammatory properties.
Other Components:
Propellant: 1,1,1,2-Tetrafluoroethane (HFA 134a).
Excipients: Stabilizers and suspension agents.
Indications
Asthma: For regular treatment in patients not adequately controlled with inhaled corticosteroids and short-acting beta2-agonists.Chronic Obstructive Pulmonary Disease (COPD): Maintenance treatment to reduce airflow obstruction and exacerbations.
Not intended for relief of acute bronchospasm.
Instructions
Usage:Administered via oral inhalation.
Shake well before use.
Follow the prescribed dosage and frequency as directed by a healthcare provider.
Precautions:
Not suitable for individuals with hypersensitivity to any of the components.
Use with caution in patients with heart disease, high blood pressure, or diabetes.
Not recommended for immediate relief of breathing difficulties—use a fast-acting reliever like salbutamol for acute symptoms.
View more about Combiwave SF250 (Salmeterol 25mcg/actuation and Fluticasone Propionate 250mcg/actuation Pressurised Inhalation) on main site